Themis Medicare incorporated in 1969, manufacturer of Active Pharmaceuticals Ingredient and Formulations.Company has four manufacturing facilities located at Vapi (Gujarat), Hyderabad (Andhra Pradesh), and Haridwar.
The company also has presence in 40 countries across the world in that international market is also included namely Europe, America and Australia. Company also have R&D facility for the development of new chemicals new process of productions of API and intermediates fermentation technology and New Drug Delivery system
History
From 1969-1995
1969- Themis Chemicals was istarted in joint venture with GEDEON Richter, Hungary.
while manufacturing Vitamin B12 in 1971 and Ethambutol Dihydrochloride in 1976 Themis Chemicals became first company in India and second company in the world .In 1985 produced RIFAMPICIN for first time in India.
1990- Company developed and manufactured HEMOLOK.
In the year of 1991-92 Company developed and manufactured ANABLOKTM – an anaesthetic
1993- Themis was only company to produce GENTAMICIN in India
1995- First company to produce unique veterinary produc in world - FUMAGILLIN.
From 1996-2007
1996- Production of LOVASTATIN made first in India and third in the world
Ministry of Science and Technology’s Department of Scientific and Industrial Research (DSIR) give award to Themis Chemical in 1997.
In 1998 Company developed Simvastatin for the first time in Asia.
In 1999 Company launched E MALTM – Alpha Beta Arteether and received award from Ministry of Science and Technology’s Department of Scientific and Industrial Research (DSIR) for the same.
2001- Company was renamed as Themis Medicare.
2002- Developed SEPGARDTM - unique wound healing agent.for the first time in india.
2003-Developed CLEOFOLTM- a Lipid free Clear Propofol Injection and OX-2 INJECTION in the world.
2004- Artemis Biotech was merged with Themis Medicare
2006- Company starts operations of its manufacturing unit located at Haridwar.
2007- Company introduced Aceclofenac Injection , for first time in the world.